{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tampa&page=9&state=Florida", "query": { "state": "Florida", "city": "Tampa", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 9115, "total_pages": 912, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tampa&page=10&state=Florida&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tampa&page=8&state=Florida&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T14:44:15.561Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03656926", "title": "Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bronchiolitis Obliterans", "Chronic Rejection of Lung Transplant", "Lung Transplant Rejection", "Lung Transplant; Complications", "Lung Transplant Failure and Rejection", "Chronic Lung Allograft Dysfunction" ], "interventions": [ { "name": "Liposomal Cyclosporine A", "type": "DRUG" }, { "name": "Standard of Care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zambon SpA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 169, "start_date": "2019-03-26", "completion_date": "2024-03-12", "has_results": true, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-10-31T14:44:15.561Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03656926" }, { "nct_id": "NCT00730691", "title": "Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Anxiety Disorder" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Vortioxetine", "type": "DRUG" }, { "name": "Duloxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 781, "start_date": "2008-06", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2013-12-18", "last_synced_at": "2026-10-31T14:44:15.561Z", "location_count": 66, "location_summary": "Anaheim, California • Beverly Hills, California • Fresno, California + 63 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00730691" }, { "nct_id": "NCT02425826", "title": "A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Parapsoriasis" ], "interventions": [ { "name": "Apremilast", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Placebo-Apremilast", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 221, "start_date": "2015-04-20", "completion_date": "2016-11-22", "has_results": true, "last_update_posted_date": "2023-06-05", "last_synced_at": "2026-10-31T14:44:15.561Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Fremont, California • Los Angeles, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fremont", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02425826" }, { "nct_id": "NCT00232908", "title": "QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "ARV regimen", "type": "DRUG" }, { "name": "enfuvirtide [Fuzeon]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 361, "start_date": "2004-06", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-10-31T14:44:15.561Z", "location_count": 103, "location_summary": "Phoenix, Arizona • Bakersfield, California • Berkeley, California + 78 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Berkeley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00232908" }, { "nct_id": "NCT07487168", "title": "Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Peritoneal Carcinomatosis" ], "interventions": [ { "name": "Mitomycin C (MMC)", "type": "DRUG" }, { "name": "Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC)", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "H. Lee Moffitt Cancer Center and Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2026-08-05", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-10-31T14:44:15.561Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07487168" }, { "nct_id": "NCT00006760", "title": "Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "ifosfamide", "type": "DRUG" }, { "name": "vinorelbine tartrate", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "30 Years", "sex": "ALL", "summary": "Up to 30 Years" }, "enrollment_count": 66, "start_date": "2001-05", "completion_date": "2012-03", "has_results": false, "last_update_posted_date": "2013-07-26", "last_synced_at": "2026-10-31T14:44:15.561Z", "location_count": 101, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 90 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00006760" }, { "nct_id": "NCT06029660", "title": "AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aortic Aneurysm, Abdominal" ], "interventions": [ { "name": "IMPEDE-FX RapidFill Implants", "type": "DEVICE" }, { "name": "EndoVascular Aneurysm Repair", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "Shape Memory Medical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2024-04-05", "completion_date": "2031-07", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-10-31T14:44:15.561Z", "location_count": 39, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 32 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Delray Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06029660" }, { "nct_id": "NCT03325010", "title": "Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Tourette Syndrome" ], "interventions": [ { "name": "Valbenazine", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 127, "start_date": "2017-10-05", "completion_date": "2018-11-16", "has_results": true, "last_update_posted_date": "2021-06-28", "last_synced_at": "2026-10-31T14:44:15.561Z", "location_count": 34, "location_summary": "Sun City, Arizona • Rogers, Arkansas • Anaheim, California + 27 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Clarita", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03325010" }, { "nct_id": "NCT05972720", "title": "A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cancer", "Relapsed/Refractory Large B-cell Lymphoma (LBCL)" ], "interventions": [ { "name": "Fludarabine (Conditional therapy)", "type": "DRUG" }, { "name": "Cyclophosphamide Monohydrate (Conditional therapy)", "type": "DRUG" }, { "name": "firi-cel (Experimental drug)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CARGO Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 101, "start_date": "2023-08-01", "completion_date": "2025-04-04", "has_results": false, "last_update_posted_date": "2025-05-15", "last_synced_at": "2026-10-31T14:44:15.561Z", "location_count": 31, "location_summary": "Little Rock, Arkansas • Duarte, California • Los Angeles, California + 24 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05972720" }, { "nct_id": "NCT05330182", "title": "LMN-201 for Prevention of C. Difficile Infection Recurrence", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Clostridioides Difficile Infection" ], "interventions": [ { "name": "LMN-201", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lumen Bioscience, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 375, "start_date": "2024-08-29", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-31T14:44:15.561Z", "location_count": 15, "location_summary": "Escondido, California • Hamden, Connecticut • Tampa, Florida + 12 more", "locations": [ { "city": "Escondido", "state": "California" }, { "city": "Hamden", "state": "Connecticut" }, { "city": "Tampa", "state": "Florida" }, { "city": "Burr Ridge", "state": "Illinois" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT05330182" } ] }